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Construction of a polyproline structure
with hydrophobic exterior using
octahydroindole-2-carboxylic acid†
Vladimir Kubyshkin* and Nediljko Budisa*
The proline analogue (2S,3aS,7aS)-octahydroindole-2-carboxylic acid (Oic) has been previously applied as
a proline substitute in pharmocologically active peptides and as a structural component of the antihyper-
tensive drug Perindopril. Herein, we describe the formation of an oligoproline structure by an Oic oligo-
mer. A series of Oic oligomers were investigated to show the structural and energetic contribution of
appended residues to the structure. NMR investigation of these oligomers revealed an all-trans amide
bond structure, and we provide evidence that a cascade-like mechanism is responsible for the all-trans
folding cooperativity. X-ray crystallography of the Oic-hexapeptide clearly demonstrates that the all-trans
structure of the Oic oligomer is a polyproline II helix. Thus, as a hydrophobic proline analog with a highly
stable trans-amide bond, Oic represents an ideal building block for hydrophobic sites of polyproline II
structures in biologically relevant contexts.
Introduction
Polyproline-II (PII) is a ubiquitous secondary structural class in
peptides and proteins that occupies a unique region on the
Ramachandran plot.1 The name PII was originally coined to
describe the structure that emerged upon mutarotation of
polyproline dissolved in water.2,3 Later discoveries showed the
abundance of PII structures in a diversity of sequence folds. It
was further shown that PII helices can consist of various poly-
amino acid sequences and do not necessarily contain proline.4
As an extended structure, PII is common in unfolded proteins,
5
and even single N-acylated amino acids exhibit spectroscopic
signatures of this conformation.6
Since PII structures do not necessarily contain proline in
the linear sequences, some have proposed that PII be renamed
‘polypeptide-II’.7 However, as the most conformationally
restricted among the canonical amino acids, proline (Fig. 1; 1)
is uniquely eﬀective at sustaining the PII structure backbone.
8,9
Accordingly, proline-rich sequences can serve as scaﬀolds for
functionalized PII motifs.
10 For example, proline-rich anti-
microbial11 and cell-penetrating peptides12 are known to adopt
the PII fold with the help of amphipathic interactions in a
membrane environment. Exploring this concept, Filon et al.
constructed an amphipathic, cell-penetrating PII peptide by
functionalizing the hydroxyl groups on an oligo-hydroxyproline
scaﬀold with polar and hydrophobic side-chains at defined
helical sites.13 In another example, Pujals et al. increased
cellular uptake of the cell-penetrating peptide SAP by replacing
proline with silaproline at the hydrophobic PII site.
14,15
Notably, a simple PII structure (3.0 residues per turn) can serve
as an eﬀective molecular ruler in spectroscopic studies (e.g.,
FRET).16
The kinetic and thermodynamic stability of the peptidyl-
prolyl trans-peptide bond has a direct impact on the stability
of proline-rich PII structures.
17 Experiments with proline
Fig. 1 Structures of proline (1, Pro), (2S,3aS,7aS)-octahydroindole-2-
carboxylic acid (2, Oic) and Perindopril (3).
†Electronic supplementary information (ESI) available: Extended experimental
details and analytical data; copies of the NMR spectra. CCDC 1510246 and
1510247. For ESI and crystallographic data in CIF or other electronic format see
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analogues showed that anchoring the proline ring in the exo-
pucker conformation increases the preference for the trans-
amide bond, which has enabled the construction of more
stable PII structures.
18,19 This eﬀect has been attributed to the
n → π* donative interaction between the carbonyl groups in
the sequence (Fig. 2).20,21 Recently, we suggested that the
donative eﬀect may be enhanced through a cascade eﬀect in
the chain of the peptide bonds, leading to cooperative for-
mation of the all-trans structural fold.22
(2S,3aS,7aS)-Octahydroindole-2-carboxylic acid (2, com-
monly referred as Oic) is a proline analogue that has been
used as a building block for the construction of pharmacologi-
cally relevant sequences, particularly bradykinin antagon-
ists.23,24 Solution NMR structures25 have demonstrated that
the Oic cyclohexane ring adopts a chair conformation in these
peptides, which may anchor the proline in the exo-pucker con-
formation. A recent theoretical study of the methylamide of
N-acetyl Oic suggested the ε backbone conformation for this
residue is predominant in solution.26
In addition, Oic is a structural constituent of the antihyper-
tension drug Perindopril (3). Early NMR studies have demon-
strated a remarkably high trans-amide ratio (>90%) for the pep-
tidyl-Oic constituent of Perindopril at high and low pH
values.27 These results suggest Oic may be a good candidate
for construction of a PII structure. Here, we demonstrate that
Oic is capable of forming a stable and regular polyproline
structure in solution, supported by the presence of a PII con-
formation in crystals of an Oic hexamer.
Results and discussion
Physicochemical comparison of Oic with (4S)- and
(5S)-methylproline
We first aimed to physicochemically characterize Oic (2) in
common model frames. Proline (1), (4S)-methylproline (4), and
(5S)-methylproline (5) were used for comparison (Fig. 3).
Reports have suggested that 4 exhibits a larger trans-content
than proline due to the exo-pucker anchoring.18,28 In contrast,
5 is expected to sustain a trans-amide content similar to that of
proline, despite the lower barrier of rotation for the amide due
to the δ(cis)-substitution.29–31
Our results indicate that Oic combines these structural
impacts of γ(cis)- and δ(cis)-substitutions. The trans-amide
content in Ac-Oic-OMe was among the highest reported to date
(Table 1) for a proline analogue (e.g., higher than that in analo-
gous (4R)-fluoro- and hydroxyproline models).21
The high trans-amide content may be a result of a stabilized
exo-pucker due to the restricted chair conformation of the
cyclohexane ring and a stronger n → π* donation imposed by
this conformational arrangement. Previously, we proposed
ΔpKa and ΔpK*a (eqn (1) and (2) for N-acetyl amino acids) as
the descriptive parameters for this interaction.22 Here, we
found that the ΔpKa and ΔpK*a values are indeed larger for 4
and 5 than for proline, whereas Oic shows the largest values,
indicating a strong n→ π* alignment.
ΔpKa ¼ pKaðtransÞ  pKaðcisÞ ð1Þ
ΔpK*a ¼ log10
Ktrans=cisðacidÞ
Ktrans=cisðsaltÞ ð2Þ
The crystal structure of Ac-Oic-OMe (Fig. 4A) illustrates
the exo-pucker anchoring by the chair cyclohexane confor-
mation.32 Careful inspection of the structure reveals that the
Fig. 3 Structures of the amino acids taken for comparison of their
physicochemical properties: 1, 2, 4, 5.
Fig. 2 trans–cis amide equilibrium of proline residue (above), exo-
pucker of the proline side chain (below).
Table 1 Thermodynamic properties of the amino acids 1, 2, 4 and 5 in model compounds as studied by 1H NMR in aqueous solution at 298 K
AA
pKa
ΔpKa ΔpK*a
Ktrans/cis
AA (ammonium)
Ac-AA-OH
(carboxyl) Ac-AA-X
s-trans s-cis X = O− X = OH X = OMe
1 (Pro) 10.68 3.55 2.85 0.70 0.67 0.81 ± 0.02 3.77 ± 0.05 4.95 ± 0.05
4 10.73 3.54 2.79 0.75 0.78 1.03 ± 0.01 6.24 ± 0.11 8.05 ± 0.13
5 10.54 3.83 3.03 0.80 0.76 0.65 ± 0.02 3.73 ± 0.06 4.64 ± 0.02
2 (Oic) 10.57 3.84 2.98 0.86 0.83 1.09 ± 0.01 7.30 ± 0.16 9.38 ± 0.40
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methyl-group of the acetyl constituent restricts the possible
flipping of the cyclohexane chair conformation, thus lock-
ing the pyrrolidine ring in the exo-pucker conformation.
Furthermore, the close proximity of the acetyl oxygen to the
carboxyl carbon stabilizes the n→ π* contact.
The cis-to-trans rotational barriers in the Ac-AA-OMe
models (Table 2) indicate that 5 and Oic have reduced
rotational barriers due to the repulsion between the acetyl
group and the 5-substituent of the proline ring in the ground
state.33 However, this eﬀect is more moderate for Oic, due to
the compact size of the CH2-unit relative to the CH3-group.
Regarding the trans-to-cis amide rotation, the reduction of the
rotational barrier is countered by the stabilizing n → π* inter-
action, which contributes to the stability of the trans-ground
state in Ac-Oic-OMe. Further analysis of the rotational
velocities in Ac-Oic-OMe indicate an enthalpy driven transition
(Fig. 4B), as expected.34 In the salt form, the rotational barriers
are heightened due to the increased amide resonance, which
is strengthened by the electrostatic interactions of the charges
(CO2
−↔ +NvC–O− attraction).
Oic in a peptide context
Next, we characterized Oic in a simple peptide context. To
achieve this, Ac-GlyGlyOicGlyGly-NH2 and Ac-GlyGlyProGlyGly-
NH2 were prepared by conventional Fmoc-solid phase peptide
synthesis starting with Rink Amide resin (see ESI† for details).
These peptides were then evaluated for their amide rotation
properties (Table 3).
Our results indicate that the Pro-to-Oic mutation increased
the relative stability of the trans-amide by approximately
−1.5 kJ mol−1, in a similar fashion to the Ac-AA-OMe model
comparison. However, the amide rotational barrier reduction
with the Pro-to-Oic mutation was much stronger than that
observed in Ac-AA-OMe models. This diﬀerence may be a
result of the greater steric interference presented by the
peptide chain. In addition, for the trans-amide fraction, the
Table 2 Amide rotation in Ac-AA-OMe models as found from 1H EXSY NMR studies in aqueous solution
AA
In Ac-AA-OMe
Ktrans/cis (at 298 K)
k310 K, s
−1 Ea, kJ mol
−1
c–t t–c c–t t–c
1 (Pro) 4.95 ± 0.05 0.033 ± 0.002 0.0070 ± 0.0005 84.8 ± 0.2 88.8 ± 0.2
4 8.05 ± 0.13 0.041 ± 0.011 0.004 ± 0.001 84.3 ± 0.7 90.3 ± 0.7
5 4.64 ± 0.02 0.238 ± 0.011 0.055 ± 0.002 79.7 ± 0.1 83.5 ± 0.1
2 (Oic) 9.38 ± 0.40 0.074 ± 0.013 0.008 ± 0.001 82.7 ± 0.5 88.5 ± 0.3
AA
In Ac-AA-O−
Ktrans/cis (at 298 K)
k340 K, s
−1 Ea, kJ mol
−1
c–t t–c c–t c–t
1 (Pro) 0.81 ± 0.02 0.075 ± 0.003 0.093 ± 0.003 91.0 ± 0.4 90.4 ± 0.3
4 1.03 ± 0.01 0.071 ± 0.009 0.066 ± 0.004 91.1 ± 0.7 91.3 ± 0.5
5 0.65 ± 0.01 1.083 ± 0.072 0.645 ± 0.028 83.4 ± 0.5 84.9 ± 0.4
2 (Oic) 1.09 ± 0.01 0.163 ± 0.003 0.153 ± 0.013 88.8 ± 0.3 88.9 ± 0.6
Fig. 4 A. X-ray crystal structure of Ac-Oic-OMe (grey – carbon, blue – nitrogen, red – oxygen). B. Kinetics of the cis–trans isomerization of
Ac-Oic-OMe in aqueous solution.
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1H{15N} single bond correlation spectra (Fig. 5) illustrate the
fundamental similarity of the peptide chain conformations in
the Pro- and Oic-containing peptides.
Crystal structure of an Oic-hexapeptide
Recently, Wilhelm et al. reported a crystal structure of a
proline hexapeptide p-BrBz-(Pro)6-OH in a PII conformation
(p-BrBz = para-bromobenzoyl).36 We prepared an analogous
hexapeptide composed of Oic residues with C-terminal amida-
tion: p-BrBz-(Oic)6-NH2. The crystal structure of this peptide
clearly demonstrates an all-trans PII fold with all pyrrolidine
rings in the exo-pucker conformations and perfect 3 residues/
1 turn periodicity.32 In contrast to the hexaproline structure
(which shows 9.0 Å per turn (ref. 36 and 37)), the hexa-Oic
structure was more compact, measuring approximately
8.6–8.7 Å per one helical turn (Fig. 6A).
Regarding the N-terminal region, the para-bromobenzoyl
moiety appeared tilted, with a N–C(vO)–C–CH (ortho) torsion
angle of approximately 68° (versus the 51° angle in the oligo-
proline structure). This tilting results from the strong spatial
clash between the aromatic ring and the δ-CH pyrrolidine
portion.38 In solution, this spatial clash substantially reduces
the rotational barrier for this amide fragment. Thus, 1H NMR
spectra of the peptide in methanol (at 298 K) demonstrate the
presence of two rotameric forms (Ktrans/cis = 2.5) with relatively
high transition velocities: 1.96 ± 0.20 and 0.84 ± 0.05 s−1 for
cis-to-trans and trans-to-cis rotations, respectively. For other
amides, the 1H ROESY spectra indicate an all-trans structure,
consistent with the crystal observations (Fig. 6B). Our mole-
cular modelling suggests that the cis-p-BrBz fragment folds
into the first turn of the PII helix, while the trans-p-BrBz frag-
ment is exposed in solution. The high content of the
N-terminal cis-form thus results from the stabilizing hydro-
phobic contacts of p-BrBz with the first three residues
Oic1–Oic3. The rotameric state of this fold also strongly influ-
ences the 1H chemical shifts of the first helical turn residues
in the two rotameric species.
Oic oligopeptides
We next wished to study the events accompanying the growth
of the polypeptide chain and the possibility of specific aggre-
gation events. We prepared a series of oligopeptides with the
structure Ac-(Oic)N-OH, where N was varied from 1 to 6. The
peptides were synthesised on an Fmoc-Oic-pre-loaded 2-chloro-
trityl resin, and the full-length peptides were cleaved mildly
with 25 vol% hexafluoroisopropanol in dichloromethane, as
described.39
The peptides were well soluble in methanol (as well as
other polar organic solvents). Peptides with N = 2–6 were very
poorly soluble in water. Conversion to salts (with phosphate
buﬀer, pH 7) enhanced their aqueous solubility. The NMR
studies with the salt Ac-(Oic)N-O
− species were then conducted
Table 3 Properties of the peptidyl-Pro and peptidyl-Oic peptide bonds
in Ac-GlyGlyAAGlyGly-NH2 peptides. Studied by
1H NMR in buﬀered
deuterium oxide solution
GGProGG GGOicGG
Ktrans/cis (at 298 K) 6.70 ± 0.20 12.3 ± 1.0
ΔGtrans/cis, kJ mol−1 −4.71 ± 0.07 −6.22 ± 0.21
E≠, kJ mol−1 c–t 81.4 ± 0.3 76.8 ± 0.1
(At 310 K) t–c 85.8 ± 0.5 82.1 ± 0.1
Fig. 5 1H{15N} sofast-HMQC spectra35 of AcGG-AA-GGNH2 peptides:
blue – AA = Pro, red – AA = Oic. Recorded in aqueous medium at 277 K.
Fig. 6 A. X-ray crystal structure of p-BrBz-(Oic)6-NH2 oligopeptide in PII conformation. B. α- and δ-CH fragment of the 1H cross-relaxation spectra
of this peptide in deuteromethanol at 298 K and 700 MHz frequency. Only the exchange due to N-terminal rotation of para-bromobenzoyl fragment
is seen in NOESY. In ROESY positive cross-peaks between α-CH and δ-CH spectral regions indicate the all-trans conformation.
Paper Organic & Biomolecular Chemistry
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in deuterium oxide. The concentration was 20 g l−1 for the
Ac-(Oic)N-O
− with N = 1–5, while the sample concentration of
Ac-(Oic)N-O
− with N = 6 was approximately 10 g l−1 due to its
poor solubility. The NMR studies were also performed in
deuteromethanol for the acidic Ac-(Oic)N-OH species at
20 g l−1 for all studied oligomers.
In deuteromethanol the 1H NOESY spectra showed a trans-
amide bond with characteristic α-CH ↔ δ-CH nuclear
Overhauser eﬀect (NOE) for the internal positions and a CH3
↔ δ-CH NOE for the N-terminal positions. The trans-amide
constituted 80% of the population for N = 1 and ≥90% for N =
2, whereas in oligomers with N ≥ 3 only the all-trans confor-
mation was observed. In this conformation, all the α-CH reson-
ances appear as doublets of doublets with one J between 10.0
and 10.5 Hz and another between 7.1 and 8.2 Hz. Thus, the
peptide backbone conformations all exhibit exceptional regu-
larity, with the exo-pucker conformation predominant in the
side-chain.40
The 1H NMR spectra for samples in deuterium oxide also
indicated the dominance of the all-trans fold; however, minor
populations of other folds were also observed (vide infra).
1H diﬀusion ordered spectra (DOSY) of the oligomeric pep-
tides demonstrated a systematically decreasing diﬀusion,
which correlated well with the increments in N. The diﬀusion
coeﬃcients obtained in DOSY were converted to molecular
volumes using the Stokes–Einstein relationship according to
eqn (3).41 These volumes were compared with theoretical
COSMO volumes obtained in semi-empirical modelling (see
eqn (4)). The resulting prediction correlated fairly well with the
experimental values for both the methanol and deuterium
oxide solutions (Fig. 7A).
log V ½A˚3 ¼ 3  log D½m2 s1 þ log T ½K
η½Pa s1  13:928
 
ð3Þ
V ½Å3 ¼ 10:9þ 1:223MW ½Da ð4Þ
In the 1H NOESY spectra, the NOEs for samples in deuter-
ium oxide appeared positive for the shorter oligomers and
negative for the longer oligomers. The sign inversion occurred
between N = 3 and 4 at 700 MHz and between N = 4 and 5 at
500 MHz, when measured at 298 K.
Next, we converted the logD values obtained in DOSY into
correlation times τc according to eqn (5) (all SI units)
41 and
plotted NOE versus τcω0, where ω0 is the angular Larmour fre-
quency. According to the theory, the sign inversion should
occur at τcω0 = 1.12,
42 which was indeed the experimental
result (Fig. 7B). Thus, the molecular sizes derived by DOSY
(spatial diﬀusion) were consistent with those derived by
NOESY (rotational diﬀusion).
τc ¼ k
2T2
126π2η2
103 log D ð5Þ
Overall the diﬀusion data indicated the absence of specific
aggregation, despite the low aqueous solubility (≤10 g l−1) of the
peptide with N = 6. However, the diﬀusion coeﬃcient error is
higher for the soluble fraction in aqueous conditions at N = 5 and
6. In addition, the applicability of the Stokes–Einstein equation,
which assumes rigid spheres, clearly indicates suﬃcient molecular
rigidity of the oligopeptide chains.43 We also found for the NOE
(y-axis) that the errors in Fig. 7B are similar for both N-terminal
(CH3 ↔ δ-CH1) and internal (α-CH1−(N−1) ↔ δ-CH2−N) positions,
only for higher oligomers. This might indicate an increase in struc-
tural rigidity for longer oligomers.
Cooperativity of oligopeptide folding
Perhaps the most interesting question addressed by the oligo-
peptide studies is the degree of acidity of the C-terminal
group. We previously observed that the acidity of the Ac-(Pro)2-
OH peptide with the trans-Pro–Pro amide bond depends on
the rotameric state of the upstream acetyl-fragment.22 Namely,
the trans–trans peptide (pKa 3.59) exhibited a drop in acidity of
approximately 0.1 pKa unit relative to the cis–trans isoform.
This result suggests cooperativity of the all-trans fold, which
we assign to a cascade of donative interactions established
between the carbonyl groups in the peptide chain.
Fig. 7 A. Dependence of the molecular volume of Ac-(Oic)N-OH on the number of residues N: black – semi-empirical calculations, red – experi-
mental in deuteromethanol (acidic form), blue – experimental in deuterium oxide (salt form); measured by 1H DOSY at 700 MHz frequency
and 298 K. B. The correlation time problem in Ac-(Oic)N-O
−. Inversion of the NOE sign in deuterium oxide samples occurs between lower and
higher oligomers; the theoretical zero-cross point is at τcω0 = 1.12. The correlation time values were obtained from experimental logD values
measured in 1H DOSY according to eqn (5). The data were collected at 700 and 500 MHz 1H frequency at 298 K.
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We also measured the C-terminal acidity of the all-trans
peptides in the Ac-(Oic)N-OH oligomers by analysing
1H NMR
chemical shifts obtained at diﬀerent pH values. In this case,
the acidity of Ac-(Oic)N-OH (N = 1) with the cis-amide (pKa
2.97) can serve as a reference. The pKa increased by 0.8–0.9
units (see Table 1) in the trans-isoform of this compound, as
the n → π* donation was stabilized by the geometry of the
Oic residue. For higher oligomers with N ≥ 2, the pKa is
further elevated by approximately 0.2–0.3 units (i.e.,
∼1.1–1.7 kJ mol−1) due to the putative cascade eﬀect (Fig. 8
and 9). The cascade eﬀect should strengthen the alignment of
the carbonyl groups throughout the peptide chain. The avail-
able data clearly indicate that the cascade eﬀect is transmitted
suﬃciently over one residue and decays very quickly through
the all-trans peptide chain. The cascade phenomenon might
therefore represent a driving force for PII nucleation in peptide
segments.
Minor conformational forms in the oligopeptides
As noted previously, in methanol samples, only the all-trans
conformation was observed in the 1H NMR spectra of
Ac-(Oic)N-OH with N ≥ 3. A more complex situation occurred
for Ac-(Oic)N-O
− peptides in phosphate buﬀer, since the
C-terminal group is a carboxylate, in which the carbonyl exhi-
bits minimal electrophilicity. Whereas at N = 1 the cis-amide
content was 48%, at N = 2 the distribution of trans–trans,
cis–trans, cis–cis and trans–cis rotamers was 79 : 11 : 7 : 2, indi-
cating a complex interdependence of the rotameric popu-
lations of two amides. For higher oligomers with N = 3–6, the
all-trans conformation is dominant. Nevertheless, some minor
fractions were persistently observed. We next aimed to identify
the source of the minor conformational forms and their popu-
lations, which should provide a proper characterization of the
relative stability of the peptide conformations.
In the aqueous samples of Ac-(Oic)N-O
−, the most promi-
nent minor resonance was δ-CH at 3.98 ppm (see Fig. 10). In
order to assign this form, we evaluated 1H EXSY spectra at
330 K. In the EXSY spectra, this minor δ-CH signal
exhibited an exchange with the N-terminal δ-CH but not the
internal δ-CH resonances. In addition, one α-CH(major) ↔
α-CH(minor) and one CH3(major) ↔ CH3(minor) exchange
together with an α-CH(minor) ↔ CH3(minor) NOE indicated
that the minor form was a result of the N-terminal rotation.
However, the intensity of this δ-CH (∼17–18% for N = 3–6)
minor signal was higher than for the other minor resonances
(α-CH and CH3, ∼6–10%), and it was remarkably higher than
that of the Ac-Oic-OMe model (10%).
Furthermore, we compared the 1H NMR spectra of the
methyl ester (Ac-(Oic)6-OMe) and salt (Ac-(Oic)6-O
−) forms in
methanol. The intensity of the (cis-Ac) δ-CH resonance
increased when changing from the salt to methyl ester. This
change was accompanied by the appearance of one additional
CH3-resonance in
1H and 1H{13C} HSQC spectra. The depen-
dence of the N-terminal rotation state on the C-terminal
charge can be explained by a cooperative formation of the all-
cis (polyproline I) structure, which is favoured in the case of
charged peptide termini.44 The estimation of the s-cis-acetyl
fragment originating from (a) the N-terminal rotation in the
all-trans structure and (b) the formation of an all-cis confor-
mation was performed by analysing three resolved CH3-reson-
ances in 1H{13C} HSQC. These were: for Ac-(Oic)6-OMe 5 (a)
and 1 (b) %, and for Ac-(Oic)6-O
− 5 (a) and 3 (b) %, respectively
(in the methanol solutions).
In deuterium oxide, the presumed all-cis fraction consti-
tuted about 2–3% for Ac-(Oic)6-O
− and was not detected for
Ac-(Oic)6-OMe. In these aqueous conditions, the cis-Ac content
due to the N-terminal rotation in the all-trans form was
10–12%, and the trans-to-cis rotation rate was about 0.02 s−1
(for Ac-(Oic)N-O
− with N = 3–6; at 330 K).
Therefore, similar to the p-BrBz-(Oic)6-NH2 peptide, the
N-terminal rotation occurs in Ac-(Oic)N-OH/O
− peptides. In
addition, the all-cis fraction might be formed at a very low, yet
detectable, level. The low percentage of the minor con-
formation explains why this fraction is obscured by the main
resonances and is only visible when combined with other
signals. Overall, the low percentage found for the minor con-
formational states indicates the high relative stability of the
major cooperative all-trans fold for the oligo-Oic chain.
Conclusions
In summary, we have demonstrated that peptidyl-Oic is
capable of creating a strong trans-amide carbonyl alignment in
peptide structures. This rotameric state is stabilized by the
anchoring of the pyrrolidine pucker in the exo-conformation
Fig. 8 Dependence of the C-terminal pKa on the oligomeric number N
in all-trans Ac-(Oic)N-OH. Measured in buﬀered aqueous solutions at
298 K by 1H NMR.
Fig. 9 Manifestation of the cascade-eﬀect in an all-trans polyproline
peptide chain.
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by the cyclohexane ring. The all-trans backbone state in oligo-
meric structures is stabilized by the high trans-amide propen-
sity of a single Oic-residue as well as the cascade eﬀect esta-
blished in the peptide chain. Furthermore, the residual
rotational freedom of the N-terminal fragment (acetyl or para-
bromobenzoyl) is the major source of alternative con-
formational states. The cascade eﬀect is the enhancement of
the original carbonyl alignment energy by a preceding residue.
For Oic, the alignment energy is enhanced by approximately
1/3–1/4 (compared to an enhancement by 1/6 for a proline oligo-
peptide, as determined previously22). As a PII stabilizing
residue, Oic represents an ideal candidate for construction of
hydrophobic sites in a plethora of biologically relevant PII
structures. We also envision that all-Oic structures might serve
as a starting point for construction of a transmembrane PII
helix, a motif non-existent in nature.
Experimental section
(2S,3aS,7aS)-Octahydroindole-2-carboxylic acid (Oic) was
obtained from commercial sources, (4S)-methylproline was
synthesized as previously described,45 and (5S)-methylproline
was synthesized according to Mohite et al.46
1-Acetyl-(2S,3aS,7aS)-octahydroindole-2-carboxylic acid
Oic (156 mg; 0.92 mmol; 1 equiv.) was mixed with acetic an-
hydride (200 μl; 2.1 mmol; 2.3 equiv.) in dichloromethane
(2 ml). After 30 min, the solvent was removed under reduced
pressure. The residue was taken up in water and freeze dried
to give 192 mg Ac-Oic as a white powder (98% yield). 1H NMR
(700 MHz, D2O, phosphate buﬀer), δ: 4.23 (dd, J = 9.5 and
7.9 Hz, s-cis) and 4.12 (dd, J = 10.1 and 8.7 Hz, s-trans) (1H,
α-CH), 3.97 (m, s-cis) and 3.82 (m, s-trans) (1H, δ-CH), 2.28 (m,
s-trans) and 2.19 (m, s-cis) (1H, γ-CH), 2.22 and 2.00 (two m,
s-cis) and 2.11 and 1.89 (two m, s-trans) (2H, β-CH2), 2.03 (s,
s-trans) and 1.83 (s, s-cis) (3H, CH3), 1.85 and 1.40 (two m,
s-trans) and 1.82 and 1.26 (two m, s-cis) (2H, CH2), 1.66 and
1.57 (two m, CH2), 1.60 and 1.09 (two m, CH2), 1.39 and 1.23
(two m, CH2).
13C{1H} (126 MHz, D2O, phosphate buﬀer),
δ: 179.9 (CO2
−), 172.7 (s-cis, NCO) and 171.7 (s-trans, NCO),
63.3 (s-cis, α-CH) and 61.5 (s-trans, α-CH), 59.9 (s-trans, δ-CH)
and 58.2 (s-cis, δ-CH), 36.6 (s-trans, γ-CH) and 35.5 (s-cis,
γ-CH), 32.7 (s-cis, β-CH2) and 31.1 (s-trans, β-CH2), 27.0
(s-trans, CH2) and 26.0 (s-cis, CH2), 25.1 and 24.9 (CH2), 23.34
and 23.32 (CH2), 20.81 (s-trans, CH3) and 20.77 (s-cis, CH3),
19.8 and 19.6 (CH2). Mass-spectrum (ESI), Th: 212.13 [M + H]
+,
234.11 [M + Na]+. [α]D = −60 (c = 1.0, methanol, 298 K).
Methyl 1-acetyl-(2S,3aS,7aS)-octahydroindole-2-carboxylate
Ac-Oic (74 mg; 0.35 mmol) was dissolved in methanol (2 ml)
and trimethylsilane (0.075 ml) was subsequently added. The
mixture was stirred overnight, methanol was removed under
reduced pressure and the residue was purified by silica gel
column using a methanol–ethyl acetate mixture (1 : 19) as
an eluent (Rf = 0.5). 79 mg of Ac-Oic-OMe was obtained as a
Fig. 10 α-CH, δ-CH region of the 1H NMR spectra of Ac-(Oic)6-O− (left) and Ac-(Oic)6-OMe (right) in deuteromethanol (bottom) and deuterium
oxide (top). Measurements were performed at 298 K in stimulated echo pulse sequence used for solvent suppression. Residual OH resonance of
deuteromethanol is marked with an asterisk. The resonances exchanged in 1H EXSY experiments (at 330 K) are marked with double-arrowed lines
below the spectra.
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colourless oil, which later crystallized (quantitative yield).
1H NMR (700 MHz, D2O), δ, only s-trans: 4.34 (dd, J = 10.0 and
8.5 Hz, 1H, α-CH), 3.89 (m, 1H, δ-CH), 3.69 (s, 3H, CH3O), 2.38
(m, 1H, γ-CH), 2.15 and 2.01 (two m, 2H, β-CH2), 2.06 (s, 3H,
CH3CvO), 1.91 and 1.37 (two m, 2H, CH2), 1.68 and 1.61 (two
m, 2H, CH2), 1.63 and 1.14 (two m, 2H, CH2), 1.41 and 1.23
(two m, 2H, CH2).
13C{1H} (126 MHz, D2O), δ, only s-trans:
175.1 (CO2Me), 172.3 (NCO), 59.5 (δ-CH), 59.0 (α-CH), 36.9
(γ-CH), 30.3 (β-CH2), 27.0 (CH2), 24.9 (CH2), 23.2 (CH2), 20.5
(CH3), 19.5 (CH2). Mass-spectrum (ESI), Th: 226.14 [M + H]
+.
[α]D = −72 (c = 1.0, methanol, 298 K).
N-Acetyl derivatives and their methyl esters for (4S)- and
(5S)-methylprolines were prepared in analogous procedures.
1-Fluorenylmethoxycarbonyl-(2S,3aS,7aS)-octahydroindole-2-
carboxylic acid
Oic (0.75 g; 4.43 mmol; 1 equiv.) was dissolved in a 10%
sodium carbonate solution (5 ml). Some water and acetone
was added, and the solution was cooled down by an ice bath. A
solution of Fmoc chloride (1.26 g; 4.87 mmol; 1.1 equiv.) in
acetone (5 ml) was added dropwise upon stirring over 40 min.
The mixture was stirred overnight at ambient temperature. The
mixture was then diluted by water to reach a volume of 250 ml.
It was then washed by diethyl ether (2 × 75 ml), acidified by
addition of solid potassium hydrogen sulphate (to pH ≤ 2) and
extracted by ethyl acetate (4 × 50 ml). Ethyl acetate fractions
were dried over sodium sulphate and filtered, and the solvent
was removed under reduced pressure. The residue was mixed
with an acetonitrile–water mixture and freeze-dried. 1.72 g of
Fmoc-Oic was obtained as a white powder (99% yield).
1H NMR (700 MHz, CD3OD), δ: 7.81 (m, 2H), 7.67–7.61 (m,
2H), 7.40 (m, 2H), 7.33 (m, 2H), 4.52 and 4.48 (two dd, J = 10.7,
5.7 Hz) and 4.34 and 4.26 (two m) (2H, CH2–O), 4.34 and 4.16
(two m, 1H, α-CH), 4.25 and 4.16 (two m, 1H, CH), 3.89 and
3.42 (two m, 1H, δ-CH), 2.36 and 2.20 (two m, 1H, γ-CH), 2.28
and 2.09, 2.24 and 1.94 (four m, 2H, β-CH2), 2.07, 180–1.68,
1.64–1.19 and 1.01 (series of multiplets, 6H, 3 × CH2).
13C{1H}
NMR (126 MHz, CD3OD), δ: 175.0 and 174.6 (CO2H), 155.0 and
154.8 (NCO), 144.12, 144.08, 144.0, 143.7, 141.5, 141.4, 141.2
and 141.1 (all C), 127.43, 127.37, 127.33, 126.81, 126.75,
124.92, 124.85, 124.5, 119.54 and 119.49 (all CH), 67.6 and
66.8 (CH2–O), 58.9 and 58.8 (α-CH), 58.1 and 57.7 (CH), 47.2
and 47.1 (δ-CH), 36.7 and 36.3 (γ-CH), 32.4 and 31.3 (β-CH2),
30.4, 27.3, 27.0, 25.3, 23.4, 23.3, 20.1 and 20.1 (all CH2). Mass-
spectrum (ESI), Th: 392.18 [M + H]+. [α]D = −28 (c = 1.0, metha-
nol, 298 K).
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